Another study, Dongiovanni et al. [11] reported that IRS1 (Gly972Arg) polymorphism affects insulin receptor activity and predisposes to liver damage and decreases hepatic insulin signaling in patients with NAFLD. The gene discussed is INSR; the disease is metabolic dysfunction-associated steatotic liver disease.